These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6980627)

  • 1. Modulation by cyclosporin A of murine natural resistance against herpes simplex virus infection. I. Interference with the susceptibility to herpes simplex virus infection.
    Armerding D; Scriba M; Hren A; Rossiter H
    Antiviral Res; 1982 May; 2(1-2):3-11. PubMed ID: 6980627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation by cyclosporin A of murine natural resistance against herpes simplex virus infection. II. Influence on the HSV-induced natural killer cell responses, macrophage activities and interferon levels.
    Armerding D; Scriba M; Kirchner H; Hren A; Rossiter H
    Antiviral Res; 1982 May; 2(1-2):13-26. PubMed ID: 6179468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the interrelation of resistance and immunity in a mouse model system of herpes-simplex type 2 infection.
    Armerding D
    Immunobiology; 1982 May; 161(5):415-28. PubMed ID: 6284636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute morphine administration reduces white blood cells' capability to induce innate resistance against HSV-1 infection in BALB/c mice.
    Jamali A; Bamdad T; Soleimanjahi H; Pakdel FG; Arefian E
    Neuroimmunomodulation; 2007; 14(1):16-23. PubMed ID: 17700036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defensive effects of a fucoidan from brown alga Undaria pinnatifida against herpes simplex virus infection.
    Hayashi K; Nakano T; Hashimoto M; Kanekiyo K; Hayashi T
    Int Immunopharmacol; 2008 Jan; 8(1):109-16. PubMed ID: 18068106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of natural killer cells by herpes-simplex virus type 2 in resistant and sensitive inbred mouse strains.
    Armerding D; Rossiter H
    Immunobiology; 1981; 158(4):369-79. PubMed ID: 6263793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual role of B cells in mediating innate and acquired immunity to herpes simplex virus infections.
    Deshpande SP; Kumaraguru U; Rouse BT
    Cell Immunol; 2000 Jun; 202(2):79-87. PubMed ID: 10896767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of secondary herpes simplex uveitis by cyclosporine.
    Oh JO; Minasi P; Grabner G; Ohashi Y
    Invest Ophthalmol Vis Sci; 1985 Apr; 26(4):494-500. PubMed ID: 2984138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Similar immune response to nonlethal infection with herpes simplex virus-1 in sensitive (BALB/c) and resistant (C57BL/6) strains of mice.
    Brenner GJ; Cohen N; Moynihan JA
    Cell Immunol; 1994 Sep; 157(2):510-24. PubMed ID: 8069930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of microgravity changes on virus infection in mice.
    Fuse A; Sato T
    J Gravit Physiol; 2004 Jul; 11(2):P65-6. PubMed ID: 16231458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune responses to vaginal or systemic infection of BALB/c mice with herpes simplex virus type 2.
    Morahan PS; Breinig MC; McGeorge MB
    J Immunol; 1977 Dec; 119(6):2030-6. PubMed ID: 72115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance to herpes simplex virus - type 1 (HSV-1).
    Lopez C
    Curr Top Microbiol Immunol; 1981; 92():15-24. PubMed ID: 6171384
    [No Abstract]   [Full Text] [Related]  

  • 13. Natural killer cellular cytotoxicity against herpes simplex virus-infected cells in Igh-1-disparate mice.
    Tamesis RR; Foster CS
    Invest Ophthalmol Vis Sci; 1990 Nov; 31(11):2224-9. PubMed ID: 1700771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment of latent herpes simplex virus type 1 infection in resistant, sensitive, and immunodeficient mouse strains.
    Ellison AR; Yang L; Voytek C; Margolis TP
    Virology; 2000 Mar; 268(1):17-28. PubMed ID: 10683323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody-dependent cellular cytotoxicity and natural killer cytotoxicity of peritoneal cells from nude mice to herpes simplex virus-infected cells.
    Kohl S; Tang JP; Loo LS
    Microbiol Immunol; 1984; 28(4):439-49. PubMed ID: 6748968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viral isolation and systemic immune responses after intracameral inoculation of herpes simplex virus type 1 in Igh-1-disparate congenic murine strains.
    Hemady R; Tauber J; Ihley TM; Opremcak EM; Foster CS
    Invest Ophthalmol Vis Sci; 1990 Nov; 31(11):2335-41. PubMed ID: 2173686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of B cell suppression on primary infection and reinfection of mice with herpes simplex virus.
    Simmons A; Nash AA
    J Infect Dis; 1987 Apr; 155(4):649-54. PubMed ID: 3029240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CXCL10/CXCR3-Dependent Mobilization of Herpes Simplex Virus-Specific CD8
    Srivastava R; Khan AA; Chilukuri S; Syed SA; Tran TT; Furness J; Bahraoui E; BenMohamed L
    J Virol; 2017 Jul; 91(14):. PubMed ID: 28468883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravascular naked DNA vaccine encoding glycoprotein B induces protective humoral and cellular immunity against herpes simplex virus type 1 infection in mice.
    Cui FD; Asada H; Kishida T; Itokawa Y; Nakaya T; Ueda Y; Yamagishi H; Gojo S; Kita M; Imanishi J; Mazda O
    Gene Ther; 2003 Dec; 10(25):2059-66. PubMed ID: 14595378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylactic Herpes Simplex Virus 2 (HSV-2) Vaccines Adjuvanted with Stable Emulsion and Toll-Like Receptor 9 Agonist Induce a Robust HSV-2-Specific Cell-Mediated Immune Response, Protect against Symptomatic Disease, and Reduce the Latent Viral Reservoir.
    Hensel MT; Marshall JD; Dorwart MR; Heeke DS; Rao E; Tummala P; Yu L; Cohen GH; Eisenberg RJ; Sloan DD
    J Virol; 2017 May; 91(9):. PubMed ID: 28228587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.